share_log
Reuters ·  May 2 02:31
Spyre Therapeutics Inc : Baird Initiates Coverage With Outperform Rating; Target Price $50
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment